Correction to: The production of UL16-binding protein 1 targeted pigs using CRISPR technology

No abstract is available for this paper.

• Publication year

  2018

• Venue

  3 Biotech

• Publication date

  2018-07-01

• Fields of study

  Art, Medicine, Biology

• Identifiers
  DOI 10.1007/s13205-018-1334-8PMID 30023148PMCID PMC6045559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Evaluation of the Safety and Regenerative Potential of Human Mesenchymal Stem Cells and Their Extracellular Vesicles in a Transgenic Pig Model of Cartilage-Bone Injury In Vivo – Preclinical Study

  2025cites this paper
• Application of Genetically Engineered Pigs in Biomedical Research

  2020cites this paper
• Xenogeneic transplantation and tolerance in the era of CRISPR-Cas9

  2019cites this paper
• The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature

  2019cites this paper
• The ethics of genome editing technologies in non-human animals : A systematic review of reasons reported in the academic literature

  2019cites this paper
• Characterization of Three Generations of Transgenic Pigs Expressing the HLA-E Gene

  2018cites this paper